Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Joseph Loscalzo, M.D., Ph.D.


This page shows the publications co-authored by Joseph Loscalzo and Kathryn Hall.
Connection Strength

  1. Drug-Placebo Additivity in Randomized Clinical Trials. Clin Pharmacol Ther. 2019 12; 106(6):1191-1197.
    View in: PubMed
    Score: 0.841
  2. Genomic Effects Associated With Response to Placebo Treatment in a Randomized Trial of Irritable Bowel Syndrome. Front Pain Res (Lausanne). 2021; 2:775386.
    View in: PubMed
    Score: 0.245
  3. Pharmacogenomics and Placebo Response in a Randomized Clinical Trial in Asthma. Clin Pharmacol Ther. 2019 12; 106(6):1261-1267.
    View in: PubMed
    Score: 0.210
  4. Systems pharmacogenomics - gene, disease, drug and placebo interactions: a case study in COMT. Pharmacogenomics. 2019 05; 20(7):529-551.
    View in: PubMed
    Score: 0.203
  5. Network analysis of the genomic basis of the placebo effect. JCI Insight. 2017 Jun 02; 2(11).
    View in: PubMed
    Score: 0.178
  6. Genetics and the placebo effect: the placebome. Trends Mol Med. 2015 May; 21(5):285-94.
    View in: PubMed
    Score: 0.154
  7. Polymorphisms in catechol-O-methyltransferase modify treatment effects of aspirin on risk of cardiovascular disease. Arterioscler Thromb Vasc Biol. 2014 Sep; 34(9):2160-7.
    View in: PubMed
    Score: 0.146
  8. NHLBI-CMREF Workshop Report on Pulmonary Vascular Disease Classification: JACC State-of-the-Art Review. J Am Coll Cardiol. 2021 04 27; 77(16):2040-2052.
    View in: PubMed
    Score: 0.058
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.